160 related articles for article (PubMed ID: 8486937)
1. Candidate recombinant vaccine for human B19 parvovirus.
Bansal GP; Hatfield JA; Dunn FE; Kramer AA; Brady F; Riggin CH; Collett MS; Yoshimoto K; Kajigaya S; Young NS
J Infect Dis; 1993 May; 167(5):1034-44. PubMed ID: 8486937
[TBL] [Abstract][Full Text] [Related]
2. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
[TBL] [Abstract][Full Text] [Related]
3. Subunit interaction in B19 parvovirus empty capsids.
Rosenfeld SJ; Young NS; Alling D; Ayub J; Saxinger C
Arch Virol; 1994; 136(1-2):9-18. PubMed ID: 7516147
[TBL] [Abstract][Full Text] [Related]
4. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
Franssila R; Hedman K
Vaccine; 2004 Sep; 22(27-28):3809-15. PubMed ID: 15315862
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
Bostic JR; Brown KE; Young NS; Koenig S
J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
[TBL] [Abstract][Full Text] [Related]
6. Generation of a parvovirus B19 vaccine candidate.
Chandramouli S; Medina-Selby A; Coit D; Schaefer M; Spencer T; Brito LA; Zhang P; Otten G; Mandl CW; Mason PW; Dormitzer PR; Settembre EC
Vaccine; 2013 Aug; 31(37):3872-8. PubMed ID: 23827313
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions.
Saikawa T; Anderson S; Momoeda M; Kajigaya S; Young NS
J Virol; 1993 Jun; 67(6):3004-9. PubMed ID: 7684458
[TBL] [Abstract][Full Text] [Related]
8. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
Gigler A; Dorsch S; Hemauer A; Williams C; Kim S; Young NS; Zolla-Pazner S; Wolf H; Gorny MK; Modrow S
J Virol; 1999 Mar; 73(3):1974-9. PubMed ID: 9971777
[TBL] [Abstract][Full Text] [Related]
9. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans.
Zuffi E; Manaresi E; Gallinella G; Gentilomi GA; Venturoli S; Zerbini M; Musiani M
Viral Immunol; 2001; 14(2):151-8. PubMed ID: 11398810
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
Kajigaya S; Fujii H; Field A; Anderson S; Rosenfeld S; Anderson LJ; Shimada T; Young NS
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4646-50. PubMed ID: 1711206
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by
Shao S; Wang Q; Jin Y; Zhang X; Liu Z; Chen S; Wu H; Yang S; Tang F; Su J; Liang Y; Zhang J; Li Q
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366508
[TBL] [Abstract][Full Text] [Related]
12. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay.
Salimans MM; van Bussel MJ; Brown CS; Spaan WJ
J Virol Methods; 1992 Sep; 39(3):247-58. PubMed ID: 1430069
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus particles as platforms for protein presentation.
Miyamura K; Kajigaya S; Momoeda M; Smith-Gill SJ; Young NS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8507-11. PubMed ID: 8078912
[TBL] [Abstract][Full Text] [Related]
14. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
Kock WC
J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
[TBL] [Abstract][Full Text] [Related]
15. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits.
Anderson S; Momoeda M; Kawase M; Kajigaya S; Young NS
Virology; 1995 Jan; 206(1):626-32. PubMed ID: 7530397
[TBL] [Abstract][Full Text] [Related]
16. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
Kerr S; O'Keeffe G; Kilty C; Doyle S
J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
[TBL] [Abstract][Full Text] [Related]
17. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.
Söderlund M; Brown CS; Spaan WJ; Hedman L; Hedman K
J Infect Dis; 1995 Dec; 172(6):1431-6. PubMed ID: 7594699
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.
Ballou WR; Reed JL; Noble W; Young NS; Koenig S
J Infect Dis; 2003 Feb; 187(4):675-8. PubMed ID: 12599085
[TBL] [Abstract][Full Text] [Related]
19. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
[TBL] [Abstract][Full Text] [Related]
20. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
Wong S; Momoeda M; Field A; Kajigaya S; Young NS
J Virol; 1994 Jul; 68(7):4690-4. PubMed ID: 8207846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
